Plunkett Research Online: Alimera Sciences Inc

ALIMERA SCIENCES INC (ALIM) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a leading cause of blindness, and outside the U.S. for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a .....


ALIMERA SCIENCES INC

Ticker: ALIM
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 678 990-5740
Fax:
Address: 6120 Windward Pkwy., Ste. 290
Alpharetta, GA 30005 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Richard EiswirthCEO/Director/President
Elliot MaltzCFO
See More
Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a leading cause of blindness, and outside the U.S. for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture